Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model.
Saoulidis
Stamatis
S
Laboratory of Infectious Diseases, 3rd Department of Pediatrics, Hippokration Hospital, Thessaloniki, Greece.
Simitsopoulou
Maria
M
Dalakiouridou
Maria
M
Walsh
Thomas J
TJ
Wheat
L Joseph
LJ
Papaioannidou
Paraskevi
P
Roilides
Emmanuel
E
D000825:Animal Structures / Q000382:microbiology; D000818:Animals; D015169:Colony Count, Microbial; D004195:Disease Models, Animal; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009503:Neutropenia / Q000150:complications*; D012233:Rhizopus / Q000187:drug effects / Q000302:isolation & purification; D012376:Rodent Diseases / Q000188:drug therapy; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics; D020096:Zygomycosis / Q000188:drug therapy*
D014230:Triazoles; D016179:Granulocyte Colony-Stimulating Factor; C101425:posaconazole